Randomized Phase II Study of Docetaxel plus Personalized Peptide Vaccination versus Docetaxel plus Placebo for Patients with Previously Treated Advanced Wild Type EGFR Non-Small-Cell Lung Cancer (Q36909904)
Jump to navigation
Jump to search
scientific article published on 4 May 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Randomized Phase II Study of Docetaxel plus Personalized Peptide Vaccination versus Docetaxel plus Placebo for Patients with Previously Treated Advanced Wild Type EGFR Non-Small-Cell Lung Cancer |
scientific article published on 4 May 2016 |
Statements
1 reference
Randomized Phase II Study of Docetaxel plus Personalized Peptide Vaccination versus Docetaxel plus Placebo for Patients with Previously Treated Advanced Wild Type EGFR Non-Small-Cell Lung Cancer (English)
1 reference
Koichi Takayama
1 reference
Shunichi Sugawara
1 reference
Yasuo Saijo
1 reference
Makoto Maemondo
1 reference
Atsushi Sato
1 reference
Shinzo Takamori
1 reference
Taishi Harada
1 reference
Tetsuro Sasada
1 reference
Tatsuyuki Kakuma
1 reference
Junji Kishimoto
1 reference
Akira Yamada
1 reference
Masanori Noguchi
1 reference
Kyogo Itoh
1 reference
Yoichi Nakanishi
1 reference
4 May 2016
1 reference
1 reference
2016
1 reference
1745108
1 reference
1 January 2016
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference